CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury

被引:56
作者
Moromizato, Y
Stechschulte, S
Miyamoto, K
Murata, T
Tsujikawa, A
Joussen, AM
Adamis, AP
机构
[1] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA
[2] Harvard Univ, Childrens Hosp, Sch Med, Surg Res Lab, Boston, MA 02115 USA
关键词
D O I
10.1016/S0002-9440(10)64643-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Extensive Limbal injury is a leading cause of irreversible blindness. The destruction of corneal limbal stem cells often results in corneal neovascularization and an optically inferior epithelium, Previous work has shown that the neovascularization after limbal injury is vascular endothelial growth factor (VEGF)-dependent, with much of the VEGF emanating from the inflammatory cells that invade the cornea, Using a relevant mouse model of limbal injury, we examined the role of CD18 and intercellular adhesion molecule-1 (ICAM-1) in limbal injury-induced neovascularization, The results show that CD18- and ICAM-1-deficient mice developed 35% (n = 5,P = 0.003) and 36% (n = 5, P = 0.002) less neovascularization than strain-specific normal controls, respectively. The corneal neutrophil counts mere similarly reduced by 51% (n = 5, P < 0.003) and 46% (n = 5, P < 0.006), respectively, When VEGF mRNA levels mere analyzed, they were reduced by 66% (n = 3, P = 0.004) and 48% Of = 3,p = 0.024), respectively, Taken together, these data identify CD-18 and ICAM-1 as mediators of the inflammatory and VEGF-dependent corneal neovascularization that follows limbal injury. The targeting of CD18 and ICAM-1 may prove useful in the treatment of inflammation-associated neovascularization in the cornea and elsewhere.
引用
收藏
页码:1277 / 1281
页数:5
相关论文
共 18 条
  • [1] Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18
  • [2] Becker MD, 1999, INVEST OPHTH VIS SCI, V40, P612
  • [3] Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
    Detmar, M
    Brown, LF
    Schön, MP
    Elicker, BM
    Velasco, P
    Richard, L
    Fukumura, D
    Monsky, W
    Claffey, KP
    Jain, RK
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (01) : 1 - 6
  • [4] FREEMAN MR, 1995, CANCER RES, V55, P4140
  • [5] Intracellular pool of vascular endothelial growth factor in human neutrophils
    Gaudry, M
    Brgerie, O
    Andrieu, V
    ElBenna, J
    Pocidalo, MA
    Hakim, J
    [J]. BLOOD, 1997, 90 (10) : 4153 - 4161
  • [6] Expression of vascular endothelial growth factor by human eosinophils: Upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5
    Horiuchi, T
    Weller, PF
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (01) : 70 - 77
  • [7] HUANG AJW, 1988, OPHTHALMOLOGY, V95, P228
  • [8] HUMAN MESANGIAL CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS PRODUCE VASCULAR-PERMEABILITY FACTOR
    IIJIMA, K
    YOSHIKAWA, N
    CONNOLLY, DT
    NAKAMURA, H
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (05) : 959 - 966
  • [9] KING PD, 1995, J IMMUNOL, V154, P6080
  • [10] OXYGEN-TENSION REGULATES THE EXPRESSION OF ANGIOGENESIS FACTOR BY MACROPHAGES
    KNIGHTON, DR
    HUNT, TK
    SCHEUENSTUHL, H
    HALLIDAY, BJ
    WERB, Z
    BANDA, MJ
    [J]. SCIENCE, 1983, 221 (4617) : 1283 - 1285